Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Sell
45
PXS Quote, Financials, Valuation and Earnings
Last price:
$3.34
Seasonality move
:
-0.83%
Day range:
$3.07 - $3.38
52-week range:
$2.47 - $4.11
Dividend yield:
0%
P/E ratio:
4.38x
P/S ratio:
0.86x
P/B ratio:
0.37x
Volume:
89.4K
Avg. volume:
28.5K
1-year change:
-18.87%
Market cap:
$34.7M
Revenue:
$51.5M
EPS (TTM):
-$0.23
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $21.7M | $25.3M | $58.3M | $45.5M | $51.5M | |
| Revenue Growth (YoY) | -21.77% | 16.72% | 130.24% | -22.07% | 13.36% | |
| Cost of Revenues | $19.6M | $27.3M | $36.3M | $23.9M | $30.2M | |
| Gross Profit | $2.1M | -$2M | $22M | $21.6M | $21.4M | |
| Gross Profit Margin | 9.88% | -7.92% | 37.75% | 47.51% | 41.45% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.4M | $2.5M | $2.5M | $3.4M | $3M | |
| Other Inc / (Exp) | $6K | -$2.9M | $55K | $24.7M | -- | |
| Operating Expenses | $4.1M | $4.1M | $4.2M | $4.9M | $4.6M | |
| Operating Income | -$1.9M | -$6.1M | $17.8M | $16.7M | $16.7M | |
| Net Interest Expenses | $5M | $3.3M | $4.4M | $5.8M | $6.5M | |
| EBT. Incl. Unusual Items | -$6.9M | -$12.3M | $13.4M | $36.8M | $12.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$6.9M | -$12.3M | $13.4M | $36.8M | $12.5M | |
| Minority Interest in Earnings | -- | -- | -- | -$201K | -$361K | |
| Net Income to Common Excl Extra Items | -$6.9M | -$12.3M | $13.4M | $36.8M | $12.5M | |
| Basic EPS (Cont. Ops) | -$1.30 | -$0.36 | $1.18 | $3.39 | $0.91 | |
| Diluted EPS (Cont. Ops) | -$1.30 | -$0.36 | $0.99 | $2.94 | $0.91 | |
| Weighted Average Basic Share | $5.4M | $36M | $10.6M | $10.7M | $10.5M | |
| Weighted Average Diluted Share | $5.4M | $36M | $12.6M | $12.6M | $10.5M | |
| EBITDA | $2.2M | -$819K | $24.3M | $22.6M | $24M | |
| EBIT | -$2.3M | -$6.1M | $17.8M | $16.7M | $16.7M | |
| Revenue (Reported) | $21.7M | $25.3M | $58.3M | $45.5M | $51.5M | |
| Operating Income (Reported) | -$1.9M | -$6.1M | $17.8M | $16.7M | $16.7M | |
| Operating Income (Adjusted) | -$2.3M | -$6.1M | $17.8M | $16.7M | $16.7M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $7M | $17M | $11.1M | $13.8M | $9.7M | |
| Revenue Growth (YoY) | 38.11% | 142.52% | -34.71% | 24.28% | -29.67% | |
| Cost of Revenues | $8.7M | $9.7M | $5.9M | $7.9M | $6.3M | |
| Gross Profit | -$1.6M | $7.3M | $5.2M | $5.9M | $3.4M | |
| Gross Profit Margin | -23.48% | 42.67% | 46.82% | 42.8% | 34.93% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $673K | $574K | $806K | $695K | $788K | |
| Other Inc / (Exp) | -$18K | $191K | -- | -- | -- | |
| Operating Expenses | $1.1M | $923K | $1.1M | $1.2M | $1.3M | |
| Operating Income | -$2.7M | $6.3M | $4.1M | $4.7M | $2.1M | |
| Net Interest Expenses | $735K | $1.2M | $1.4M | $1.8M | $1.4M | |
| EBT. Incl. Unusual Items | -$3.5M | $5.3M | $3.1M | $3.5M | $1.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$3.4M | $5M | $3.1M | $3.6M | $1.2M | |
| Minority Interest in Earnings | -- | -- | -$261K | -$234K | -$25K | |
| Net Income to Common Excl Extra Items | -$3.5M | $5.3M | $3.1M | $3.5M | $1.2M | |
| Basic EPS (Cont. Ops) | -$0.39 | $0.48 | $0.29 | $0.34 | $0.11 | |
| Diluted EPS (Cont. Ops) | -$0.40 | $0.40 | $0.27 | $0.31 | $0.11 | |
| Weighted Average Basic Share | $9.6M | $10.6M | $10.7M | $10.6M | $10.4M | |
| Weighted Average Diluted Share | $9.6M | $12.6M | $12.6M | $11.9M | $10.5M | |
| EBITDA | -$1.3M | $8M | $5.5M | $6.7M | $4.2M | |
| EBIT | -$2.7M | $6.3M | $4.1M | $4.7M | $2.1M | |
| Revenue (Reported) | $7M | $17M | $11.1M | $13.8M | $9.7M | |
| Operating Income (Reported) | -$2.7M | $6.3M | $4.1M | $4.7M | $2.1M | |
| Operating Income (Adjusted) | -$2.7M | $6.3M | $4.1M | $4.7M | $2.1M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $21.7M | -- | $50.6M | $52.8M | $40.5M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $23.2M | -- | $27M | $26.7M | $28.4M | |
| Gross Profit | -$1.4M | $13M | $23.6M | $26.1M | $12.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.5M | $1.9M | $3.4M | $2.9M | $6.1M | |
| Other Inc / (Exp) | -$477K | -$2.4M | $7.7M | $17M | -- | |
| Operating Expenses | $4M | -- | $4.8M | $4.6M | $7.9M | |
| Operating Income | -$5.4M | -- | $18.8M | $21.5M | $4.1M | |
| Net Interest Expenses | $3.7M | $2.9M | $5.2M | $6.5M | $6M | |
| EBT. Incl. Unusual Items | -$9.5M | $4.7M | $21.7M | $34.3M | -$89K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$9.6M | -- | $21.7M | $34.1M | -$402K | |
| Minority Interest in Earnings | -- | -- | -$261K | -$121K | -$361K | |
| Net Income to Common Excl Extra Items | -$9.5M | -- | $21.7M | $34.3M | -$89K | |
| Basic EPS (Cont. Ops) | -$1.33 | -- | $1.97 | $3.19 | -$0.23 | |
| Diluted EPS (Cont. Ops) | -$1.32 | $0.19 | $1.70 | $2.78 | -$0.23 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$363K | -- | $24.6M | $28.5M | $12.2M | |
| EBIT | -$5.4M | $9.8M | $18.8M | $21.5M | $4.1M | |
| Revenue (Reported) | $21.7M | -- | $50.6M | $52.8M | $40.5M | |
| Operating Income (Reported) | -$5.4M | -- | $18.8M | $21.5M | $4.1M | |
| Operating Income (Adjusted) | -$5.4M | $9.8M | $18.8M | $21.5M | $4.1M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $17.2M | $33.1M | $32.2M | $39.5M | $28.5M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $18M | $19.1M | $17.8M | $20.6M | $18.9M | |
| Gross Profit | -$758K | $14M | $14.4M | $18.9M | $9.6M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.9M | $1.3M | $2.8M | $2.2M | $5.4M | |
| Other Inc / (Exp) | -$476K | $11K | $7.7M | -- | -- | |
| Operating Expenses | $3.2M | $2M | $3.8M | $3.5M | $6.8M | |
| Operating Income | -$4M | $12M | $10.7M | $15.4M | $2.8M | |
| Net Interest Expenses | $2.5M | $2.1M | $3.8M | $4.9M | $4.4M | |
| EBT. Incl. Unusual Items | -$6.9M | $10.1M | $15M | $12.4M | -$223K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$6.8M | $5M | $15.1M | $12.5M | -$233.2K | |
| Minority Interest in Earnings | -- | -- | -$261K | -$181K | -$181K | |
| Net Income to Common Excl Extra Items | -$6.9M | $10.1M | $15M | $12.4M | -$223K | |
| Basic EPS (Cont. Ops) | -$0.83 | $0.91 | $1.36 | $1.14 | -$0.00 | |
| Diluted EPS (Cont. Ops) | -$0.84 | $0.77 | $1.19 | $1.02 | -$0.00 | |
| Weighted Average Basic Share | $26.2M | $31.8M | $32.2M | $31.5M | $31.2M | |
| Weighted Average Diluted Share | $26.2M | $35.9M | $37.8M | $36.4M | $31.3M | |
| EBITDA | -$789K | $15.2M | $14.9M | $20.7M | $8.9M | |
| EBIT | -$4.4M | $12M | $10.7M | $15.4M | $2.8M | |
| Revenue (Reported) | $17.2M | $33.1M | $32.2M | $39.5M | $28.5M | |
| Operating Income (Reported) | -$4M | $12M | $10.7M | $15.4M | $2.8M | |
| Operating Income (Adjusted) | -$4.4M | $12M | $10.7M | $15.4M | $2.8M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.6M | $7.1M | $7.9M | $54.5M | $38.2M | |
| Short Term Investments | -- | -- | -- | $20M | $17M | |
| Accounts Receivable, Net | $663K | $1.7M | $10.5M | $5M | $5M | |
| Inventory | $681K | $1.6M | $1.9M | $957K | $1.9M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $133K | $186K | $204K | $226K | $706K | |
| Total Current Assets | $5.4M | $19.1M | $21.1M | $60.9M | $46.1M | |
| Property Plant And Equipment | $83.8M | $119.7M | $114.2M | $101.9M | $140.2M | |
| Long-Term Investments | -- | $2.8M | $2.9M | $1.8M | $1.4M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $2.4M | $2.8M | $2.3M | $1.9M | $1.4M | |
| Total Assets | $93.2M | $142.6M | $139M | $166.3M | $188.9M | |
| Accounts Payable | $3.6M | $3.1M | $2.6M | $1.7M | $2.1M | |
| Accrued Expenses | $677K | $1.1M | $967K | $646K | $1.5M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $8.3M | $22.8M | $12.6M | $10.1M | $12.3M | |
| Long-Term Debt | $55.3M | $70.9M | $65M | $55.4M | $77M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $63.6M | $93.7M | $77.6M | $65.5M | $89.2M | |
| Common Stock | $22K | $42K | $11K | $11K | $11K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $29.6M | $48.9M | $61.4M | $96.5M | $93.4M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | $4.3M | $6.3M | |
| Total Equity | $29.6M | $48.9M | $61.4M | $100.9M | $99.7M | |
| Total Liabilities and Equity | $93.2M | $142.6M | $139M | $166.3M | $188.9M | |
| Cash and Short Terms | $1.6M | $7.1M | $7.9M | $54.5M | $38.2M | |
| Total Debt | $58.6M | $82.6M | $70.9M | $61M | $84.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $8.1M | $4.6M | $32.6M | $42.4M | $42.9M | |
| Short Term Investments | -- | -- | -- | $17M | -- | |
| Accounts Receivable, Net | $1.9M | $9M | $2.4M | $9.3M | $1.3M | |
| Inventory | $1.1M | $2.8M | $1.8M | $1M | $542K | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $260K | $315K | $257K | $621K | -- | |
| Total Current Assets | $11.4M | $18.7M | $37M | $53.3M | $44.9M | |
| Property Plant And Equipment | $100.3M | $115.7M | $123.5M | $141.9M | $135.2M | |
| Long-Term Investments | $2.8M | $2.8M | $1.5M | $1.4M | $1.4M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $2.7M | $2.3M | $1.5M | $1.4M | -- | |
| Total Assets | $115.7M | $138.1M | $163.8M | $198M | $183.8M | |
| Accounts Payable | $2.7M | $3.5M | $2.9M | $1.5M | $1.7M | |
| Accrued Expenses | $724K | $867K | $1.1M | $1.1M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $9.4M | $16.7M | $14.7M | $11.3M | $13.1M | |
| Long-Term Debt | $54M | $66.5M | $69.4M | $78.9M | $71.3M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $63.4M | $83.2M | $84.1M | $90.2M | $84.4M | |
| Common Stock | $38K | $42K | $11K | $11K | $11K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | $6.2M | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | $4.3M | $6.5M | $6.1M | |
| Total Equity | $52.2M | $54.9M | $79.7M | $107.8M | $99.4M | |
| Total Liabilities and Equity | $115.7M | $138.1M | $163.8M | $198M | $183.8M | |
| Cash and Short Terms | $8.1M | $4.6M | $32.6M | $42.4M | $42.9M | |
| Total Debt | $59.9M | $72.3M | $76.4M | $86.4M | $78.9M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$6.9M | -$12.3M | $13.4M | $36.8M | $12.5M | |
| Depreciation & Amoritzation | $4.4M | $5.3M | $6.5M | $5.9M | $7.3M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$8.6M | $5.2M | -$12.4M | $6.2M | -$283K | |
| Change in Inventories | -$180K | -$886K | -$344K | $954K | -$932K | |
| Cash From Operations | -$13M | -$1.8M | $8.3M | $21.2M | $18.8M | |
| Capital Expenditures | $567K | $43.2M | $3.6M | $32M | $45.2M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $12.6M | -$43.2M | $5M | $16.7M | -$36.3M | |
| Dividends Paid (Ex Special Dividend) | -$69K | $537K | $871K | $797K | $8.1M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $15.3M | $59.5M | -- | $34.5M | $31M | |
| Long-Term Debt Repaid | -$19.9M | -$37M | -$12M | -$44.8M | -$7.3M | |
| Repurchase of Common Stock | -- | -- | -- | $1.2M | $1.5M | |
| Other Financing Activities | -$582K | -$3.4M | -$11K | $4.8M | $5.5M | |
| Cash From Financing | -$739K | $50.8M | -$12.9M | -$11.7M | $3.7M | |
| Beginning Cash (CF) | $5.2M | $7.1M | $7.9M | $34.5M | $21.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$1.1M | $5.8M | $315K | $26.2M | -$13.7M | |
| Ending Cash (CF) | $4M | $13M | $8.3M | $60.7M | $7.5M | |
| Levered Free Cash Flow | -$13.6M | -$45M | $4.7M | -$10.8M | -$26.3M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$3.4M | $5M | $3.1M | $3.6M | $1.2M | |
| Depreciation & Amoritzation | $1.4M | $1.4M | $1.4M | $2.1M | $2.2M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$734.3K | -$3.5M | $1.8M | -$4M | -$1.4M | |
| Change in Inventories | $428.6K | $670.6K | -$930.7K | $1.1M | $936.4K | |
| Cash From Operations | -$2.5M | $2.2M | $7.6M | $2M | $3.8M | |
| Capital Expenditures | $16.7M | -$114K | $29.4M | $649.9K | $311.2K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$16.7M | -$159.3K | -$24.9M | -$521.7K | -$209.2K | |
| Dividends Paid (Ex Special Dividend) | $161.8K | $191.4K | $197.1K | $262.4K | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $13.5M | -- | $19M | -- | -- | |
| Long-Term Debt Repaid | -$1.2M | -$1.6M | -$1.5M | -$2M | -- | |
| Repurchase of Common Stock | -- | -- | $589.9K | $482.2K | $2K | |
| Other Financing Activities | -$909K | -$1K | $4.4M | -$90K | -- | |
| Cash From Financing | $17.2M | -$1.4M | $16.9M | -$2.5M | -$2.1M | |
| Beginning Cash (CF) | $8.1M | $4.6M | $32.6M | $25.4M | $28.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$2M | $690.5K | -$362.3K | -$981.6K | $1.6M | |
| Ending Cash (CF) | $6.1M | $5.3M | $32.2M | $24.4M | $30.5M | |
| Levered Free Cash Flow | -$19.1M | $2.4M | -$21.8M | $1.4M | $3.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$9.6M | -- | $21.7M | $34.1M | -$402K | |
| Depreciation & Amoritzation | $5M | -- | $6M | $7M | $8.2M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$452.6K | -- | $4.1M | -$6.8M | $7.2M | |
| Change in Inventories | -$636.8K | -- | $975.6K | $755.4K | $553.6K | |
| Cash From Operations | -$7.2M | -- | $24.9M | $13.9M | $17.6M | |
| Capital Expenditures | $20.4M | $21.8M | $29.5M | $47.9M | -$246.4K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$19.9M | -- | -$286K | -$19.4M | $3.4M | |
| Dividends Paid (Ex Special Dividend) | $385K | -- | $834.2K | $8.3M | -$146.9K | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $30.5M | $29M | $34.5M | $31M | -- | |
| Long-Term Debt Repaid | -$29M | -$19.3M | -$30.7M | -$20.9M | -- | |
| Repurchase of Common Stock | -- | -- | $681.6K | $3.9M | -$1.6M | |
| Other Financing Activities | -$3.4M | -- | $4.8M | $5.5M | -- | |
| Cash From Financing | $34M | -- | $2.6M | -$2.2M | -$16.8M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $6.9M | -- | $27.2M | -$7.8M | $4.2M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$27.6M | -- | -$4.7M | -$34M | $17.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$6.8M | $5M | $15.1M | $12.5M | -$233.2K | |
| Depreciation & Amoritzation | $3.6M | $1.4M | $4.3M | $5.3M | $6.4M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$583.3K | -$3.5M | $8.9M | -$4.1M | $3.4M | |
| Change in Inventories | -$378.4K | $670.6K | $129.9K | -$63.7K | $1.4M | |
| Cash From Operations | -$3.6M | $2.2M | $19.9M | $12.7M | $11.7M | |
| Capital Expenditures | $19.8M | -$114K | $29.4M | $45.5M | $679.9K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$19.8M | -$159.3K | -$420.8K | -$36.5M | $2.7M | |
| Dividends Paid (Ex Special Dividend) | $10.8K | $191.4K | $605K | $8.1M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $30.5M | -- | $34.5M | $31M | -- | |
| Long-Term Debt Repaid | -$28.2M | -$10.5M | -$29.2M | -$5.4M | -$3.9M | |
| Repurchase of Common Stock | -- | -- | $681.6K | $3.4M | $282.4K | |
| Other Financing Activities | -$3.1M | -$1K | $4.8M | $5.5M | -$1K | |
| Cash From Financing | $30.1M | -$1.4M | $4.6M | $14.1M | -$6.4M | |
| Beginning Cash (CF) | $31.2M | $8.6M | $93.6M | $75.1M | $79.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $6.6M | $690.5K | $24.1M | -$9.7M | $8M | |
| Ending Cash (CF) | $37.8M | $5.3M | $117.7M | $65.4M | $87.6M | |
| Levered Free Cash Flow | -$23.4M | $2.4M | -$9.6M | -$32.8M | $11M | |
Get PXS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PXS
Sector
P/E ratio
4.38x
19.87x
PEG ratio
0.02x
0.18x
P/B ratio
0.37x
1.75x
Price / LTM sales
0.86x
0.89x
Growth Metrics
PXS
Sector
Revenue growth
-29.67%
4.86%
Earnings growth
-63.37%
5.46%
Revenue (5-year growth)
13.18%
4.23%
Earnings forecast
--
$0.34
Profitability
PXS
Sector
Profitability FY 2024
$21.4M
$249M
Return on invested capital
-0.05%
4.69%
Return on assets
-0.05%
3.09%
Return on equity
-0.09%
8.11%
Earnings Date
Last Earnings Date
Nov
20
Next Earnings Date
Mar
12
Estimated Next Earnings Date
Feb
19
Balance Sheet
PXS
Sector
Total cash
$42.9M
$136.8M
Short term investments
$17M
$32.3M
Total assets
$188.9M
$1.4B
Long term debt
$78.9M
$49.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
67
Is GOOG Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Buy
53
Is GOOGL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Alerts
Buy
80
BNR alert for Jan 15
Burning Rock Biotech Ltd. [BNR] is up 20.06% over the past day.
Sell
37
TCOM alert for Jan 15
Trip.com Group Ltd. [TCOM] is down 2.64% over the past day.
Sell
39
DAVE alert for Jan 15
Dave, Inc. [DAVE] is up 3.08% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
